Wellfully Ltd (WFL)

WFL Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

WFL's Principal Activity is the research and development for its Dermaportation and ETP transdermal drug delivery technologies.

Announcements

Company Overview

Dividend History

Ex-Date	Amount	Franking	Gross	Type	Payable
03/03/2010	$0.02	100%	$0.0286	Interim	31/03/2010
26/08/2009	$0.03	100%	$0.0429	Final	15/09/2009
16/03/2009	$0.05	100%	$0.0714	Interim	06/04/2009

Show All

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM)	$0.00
Gross DPS(TTM)	$0.00
Dividend yield
Gross yield
Payout Ratio	--
DRP	No
DRP Features	-

Directors & Management

Name	Title	Since	Bio
Mr Paul Peros	Chief Executive Officer	Apr 2020
Mr Cameron Reynolds	Non-Executive Director	Jul 2018	Mr Cameron Reynolds Non-Executive Director Mr Reynolds is the President, Chief Executive Officer (CEO) and Director of VolitionRX, a biotech company which listed on the New York Stock Exchange (NYSE) in February 2015 after being founded by Mr Reynolds in 2010. He has experience in the management, structuring, and strategic planning of start-up companies and has held positions including CEO, Chief Financial Officer and Non-Executive Director of public and private enterprises.
Mr Antonio (Tony) Della Vergiliana Varano	Non-Executive Director,Non-Executive Chairman	May 2018	Mr Antonio (Tony) Della Vergiliana Varano Non-Executive Director,Non-Executive Chairman Mr Varano has more than 30 years experience across Australia, Europe and the USA, operating and managing successful entrepreneurial, corporate and investment pursuits. This experience has covered start up, funding and growth, corporate operations, executive management and business exits. His expertise spans retail, cosmetics, skincare, real estate, agriculture, publishing, construction, entertainment and the arts. New York-based, Mr Varano holds Board and investment positions in several companies he has either founded or invested in at an early stage. Mr Varano studied business at the Western Australian Institute of Technology.
Mr Steven Lorn Schapera	Non-Executive Director	Aug 2017	Mr Steven Lorn Schapera Non-Executive Director Mr Schapera founded the BECCA Cosmetic brand (www.beccacosmetics.com) and commercialised it into a range of cosmetic products that were distributed throughout Europe, Asia and North America. Mr Schapera guided BECCA from its infancy through to being a global player in the luxury cosmetic space. In 2016, BECCA was sold to Estee Lauder for more than US$230 million. Mr Schapera is Chairman of BECCA Holdings Pty. Ltd.; he serves as a non-executive Director on the Board of Invincible Brands GmbH., arguably Europe's most successful influencermarketing business, and recently assisted with their partial sale to Henkel. He is also Founder and Managing Director of London-based Lab Brands Limited and is a non-executive Director of Wild Nutrition Ltd, a fast-growing player in the vitamin and mineral supplement space.
Mr John Joseph Palermo	Company Secretary	May 2008
Mr Jeffrey David Edwards	Managing Director	Oct 2004	Mr Jeffrey David Edwards Managing Director Mr Edwards is responsible for Licensing and Partnering programs with Procter & Gamble and other partners, Intellectual Property and Technology Innovations. He is the recipient of an Australia Design award, and Product Innovation and Partnering awards from Procter & Gamble Consumer Products Divisions.

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
22/12/20	Steven Schapera	Buy	+180,291	$0.14	$25,240	On-market trade
22/09/20	Antonio (Tony) Varano	Transfer	1,125,000	$0.10	$112,500	Off-market transfer
22/09/20	Steven Schapera	Transfer	1,125,000	$0.10	$112,500	Off-market transfer
19/08/20	Antonio (Tony) Varano	Transfer	1,402,330	$0.015	$21,034	Off-market transfer
19/08/20	Antonio (Tony) Varano	Transfer	1,402,330	$0.015	$21,034	Off-market transfer
19/08/20	Antonio (Tony) Varano	Issued	66,667	$0.10	$6,666	Rights issue
19/08/20	Antonio (Tony) Varano	Issued	1,402,330	$0.10	$140,233	Director remuneration
19/08/20	Steven Schapera	Issued	2,250,000	$0.10	$225,000	Placement
19/08/20	Steven Schapera	Issued	1,733,013	$0.10	$173,301	Director remuneration
19/08/20	Cameron Reynolds	Issued	562,500	$0.10	$56,250	Director remuneration
30/04/20	Christopher Quirk	Transfer	1,158,831	$0.015	$17,382	Off-market transfer
30/04/20	Christopher Quirk	Transfer	1,158,831	$0.015	$17,382	Off-market transfer
09/10/18	Steven Schapera	Buy	+1,100,000	$0.022	$24,287	On-market trade
07/08/18	Steven Schapera	Buy	+2,459,999	$0.029	$70,880	On-market trade
15/05/18	Steven Schapera	Buy	+349,151	$0.027	$9,331	On-market trade
15/05/18	Steven Schapera	Buy	+300,000	$0.027	$8,100	On-market trade
09/05/18	Steven Schapera	Buy	+700,000	$0.027	$19,059	On-market trade
08/05/18	Steven Schapera	Buy	+1,366,000	$0.027	$37,193	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Steven Schapera	22/12/2020	N/A	3,499,504	N/A	N/A
Antonio (Tony) Varano	22/09/2020	1,402,330	2,793,997	N/A	N/A
Cameron Reynolds	19/08/2020	0	562,500	N/A	N/A
Jeffrey Edwards	30/06/2020	N/A	2,021,550	N/A	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Via Pastura Limited	6,720,000	4.59%
Mr Danny Pavlovich <Pavlovich Family A/C>	3,825,000	2.61%
Sunset Capital Management Pty Ltd <Sunset Superfund A/C>	3,500,000	2.39%
RFID Systems Pty Ltd <The Rfid Consulting A/C>	2,950,000	2.01%
The Brand Laboratories Fz Llc	2,858,013	1.95%
Citicorp Nominees Pty Ltd	2,533,738	1.73%
Rokamaho Pty Ltd <Pumba Blossom A/C>	1,903,334	1.30%
Virtus Capital Pty Ltd	1,846,559	1.26%
Antonio Varano Della Vergiliana	1,402,330	0.96%
Jeb Holdings Pty Ltd <Edwards Family A/C>	1,371,886	0.94%
Jomima Pty Ltd <Internal Equity A/C>	1,207,180	0.82%
Dr Alok Jhamb	1,160,000	0.79%
Sabina Pty Ltd <Australian Enterprise A/C>	1,125,000	0.77%
J P Morgan Nominees Australia Pty Ltd	1,074,945	0.73%
Mr Peter Fedele	981,657	0.67%
HSBC Custody Nominees (Australia) Ltd	910,708	0.62%
Daughters & Co Pty Ltd <Daughters & Co A/C>	881,608	0.60%
Mr Jason Michael Harkess	820,000	0.56%
Mulloway Pty Ltd <John Hartley Poynton Fam A/C>	750,000	0.51%
Provendore Pty Ltd <The Wilks Super Fund A/C>	740,000	0.51%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month